•  
  •  
  •  
  •  

2025-12-23 11:15:09

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  INE797F01012

Research

  • Maintain SELL on Jubilant FoodWorks - No big fireworks unlike in other discretionary names - HDFC Securities
  • Jubilant Foodworks - Soft SSSG in the quarter but record store openings points to strong outlook ahead - YES Securities

Stock Report

  • Jubilant FoodWorks Limited fixes record date for stock split
  • Jubilant FoodWorks Ltd announces resignation of CEO
  • Jubilant FoodWorks updates on merger
  • Jubilant FoodWorks Ltd board approves stock split
  • Domino's Pizza achieves a Milestone of 1500 Restaurants in India
  • Jubilant Foodworks launches first POPEYES® restaurant in India at Bengaluru
  • Jubilant FoodWorks Limited to consider stock split
  • Jubilant Foodworks Ltd announces acquisition of 35% stake in Hashtag Loyalty Private Limited
  • Jubilant Foodworks Limited reports Q2FY22 earnings

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024